Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
European Urology|December 30, 2011
Finding the correct starting dose for onabotulinumtoxinAChristopher R Chapple
BJU International|February 18, 2017
London welcomes the European Association of Urology (EAU)Christopher R Chapple
European Urology|June 19, 2012
What do we really know about antimuscarinic therapy for adult neurogenic detrusor overactivity?Christopher R Chapple
Current Opinion in Urology|January 9, 2020
Contemporary surgical management of stress urinary incontinenceChristopher R Chapple
Asian Journal of Urology|May 8, 2019
Moving beyond BPH - A contemporary update on male LUTSChristopher R Chapple
Current Opinion in Urology|June 8, 2015
Current controversies in functional urologyChristopher R Chapple
European Urology|February 8, 2018
Oral Pain and Morbidity with Buccal Mucosa Grafts for Substitution Urethroplasty: Closure or NotChristopher R Chapple
Reviews in Urology|September 21, 2006
A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract SymptomsChristopher R Chapple
Expert Opinion on Pharmacotherapy|November 18, 2006
Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladderChristopher R Chapple
Expert Opinion on Investigational Drugs|October 27, 2004
Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladderChristopher R Chapple
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
European Urology|December 30, 2011
Finding the correct starting dose for onabotulinumtoxinAChristopher R Chapple
BJU International|February 18, 2017
London welcomes the European Association of Urology (EAU)Christopher R Chapple
European Urology|June 19, 2012
What do we really know about antimuscarinic therapy for adult neurogenic detrusor overactivity?Christopher R Chapple
Current Opinion in Urology|January 9, 2020
Contemporary surgical management of stress urinary incontinenceChristopher R Chapple
Asian Journal of Urology|May 8, 2019
Moving beyond BPH - A contemporary update on male LUTSChristopher R Chapple
Current Opinion in Urology|June 8, 2015
Current controversies in functional urologyChristopher R Chapple
European Urology|February 8, 2018
Oral Pain and Morbidity with Buccal Mucosa Grafts for Substitution Urethroplasty: Closure or NotChristopher R Chapple
Reviews in Urology|September 21, 2006
A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract SymptomsChristopher R Chapple
Expert Opinion on Pharmacotherapy|November 18, 2006
Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladderChristopher R Chapple
Expert Opinion on Investigational Drugs|October 27, 2004
Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladderChristopher R Chapple
Pageof 28